All-trans-Retmoic Acid Inhibits Growth of Human Pancreatic Cancer Cell Lines

Pancreas

Volumn 12, Issue 2, 1996, Pages 189-195

  Bold, Richard J ^a,b   Ishizuka, Jin ^a   Townsend Jr , Courtney M ^a   Thompson, James C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

All trans retinoic acid; Growth inhibition; Pancreatic tumor

Indexed keywords

RETINOIC ACID;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL VIABILITY; DIETARY INTAKE; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; CELL DIVISION; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030071519     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199603000-00014     Document Type: Article

References (45)

1. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991;5:2924-33.
2. Glass CK, DiRenzo J, Kurokawa R, Han Z. Regulation of gene expression by retinoic acid receptors. DNA Cell Biol 1991;10:623-38.
3. Gudas LJ. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ 1992;3:655-62.
4. Bertino JR. Meeting focus: retinoic acid shows promise in treating wider range of cancers. Biother Rep 1992;2:1-4.
5. Mori S. The changes in the para-ocular glands which follow the administration of diets low in fat-soluble vitamin A; with notes of the effects of the same diets on the solitary glands and the mucosa of the larynx and trachea. Bull Johns Hopkins Hosp 1927;33:357-9.
6. Wolbach SB, Hove PR. Tissue changes after deprivation of fat-soluble A-vitamin. J Exp Med 1925;42:753-78.
7. Schleicher RL, Moon RC, Patel MK, Beattie CW. Influence of retinoids on growth and metastasis of hamster melanoma in athymic mice. Cancer Res 1988;48:1465-9.
8. Halter SA, Fraker LD, Adcock D, Vick S. Effect of retinoids on xenotransplanted human mammary carcinoma cells in athymic mice. Cancer Res 1988;48:3733-6.
9. Tallman MS, Wiernik PH. Retinoids in cancer treatment. J Clin Pharmacol 1992;32:868-88.
10. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992;3:513-26.
11. Jetten AM, Nervi C, Vollberg TM. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J Natl Cancer Inst 1992;13:93-100.
12. Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. J Natl Cancer Inst 1984;73:1381-6.
13. Lippman SM, Hong WK. Editorial: Not yet standard: retinoids versus second primary tumors. J Clin Oncol 1993;11: 1204-7
14. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22.
15. Lippman SM, Hong WK. 13-cis-Retinoic acid and cancer chemoprevention. J Natl Cancer Inst 1992;13:111-5.
16. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980;77: 2936-40.
17. Huang ME Ye YC, Chen SR, et al. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-72.
18. Smith MA, Adamson PC, Balis FM, et al. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid m pediatric patients with cancer. J Clin Oncol 1992;10:1666-73.
19. Stimson WH. Vitamin A intoxication in adults. N Engl J Med 1961;265:369-73.
20. Ortanos CE, Ehlert R, Gollnick H. The retinoids: a review of their clinical, pharmacology and therapeutic use. Drugs 1987;34:459-503.
21. Gollnick H, Ehlert R, Rinck G, Orfanos CE. Retinoids: an overview of pharmacokinetics and therapeutic value. Methods Enzymol 1990;190:291-304.
22. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26.
23. Warshaw AL, Castillo CF-D. Pancreatic carcinoma. N Engl J Med 1992;327(7):455-65.
24. Debas HT, Mulvihill SJ. Neuroendocrine gut neoplasms. Arch Surg 1994;129:965-72.
25. Norton JA. Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 1994;2:81-144.
26. Evers BM, Townsend CM Jr, Upp JR, et al. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 1991;101:303-11.
27. Committee on Care and Use of the "Nude" Mouse. Guide for the care and use of the nude (thymus-deficient) mouse in biomedical research. ILAR News 1976;19:M1-20.
28. Moriotti A, Durham J, Frederickson R, Miller R, Botcher F, McWhinney M. Actions and interactions of estradiol and retinoic acid in mouse anterior prostate gland. J Reprod 1987;37:1023-35.
29. Ogur M, Rosen G. The nucleic acids of plant tissues. I. The extraction and estimations of deoxypentose nucleic acid and pentose nucleic acid. Arch Biochem 1950;25:262-76.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
31. Burton K. A study of the conditions and mechanisms for the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acids. Biochemistry 1956;62:315-23.
32. Dische Z. Qualitative and quantitative colorimetric estimation of heptoses. J Biol Chem 1953;204:983-97.
33. Bukowski RM, Fleming TR, Macdonald JS, Oishi N, Taylor SA, Baker LH. Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. Cancer 1993;71:322-5.
34. Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD. Evidence for a 15:17 translocation in every patient with acute promyelocytic leukemia. Am J Med 1984; 76:827-41.
35. Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor PML. Cell 1991;66:663-74.
36. 1-mediated autocrine inhibition. Blood 1991;77:1248-55.
37. Glick AB, McCune BK, Abdulkarem N, et al. Complex regulation of TGFβ expression by retinoic acid in the vitamin A-deficient rat. Development 1991;111:1081-6.
38. Hudson LG, Santon JB, Glass CK, Gill GN. Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell 1990;62: 1165-75.
39. Kim JS, Steck PA, Gallick GE, et al. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells. J Natl Cancer Inst 1992;13:101-10.
40. Sporn MB, Roberts AB. Interactions of retinoids and transforming growth factor-β in regulation of cell differentiation and proliferation. Mol Endocrinol 1991;5:3-7.
41. Ishizuka J, Beauchamp RD, Sato K, Townsend CM Jr, Thompson JC. Novel action of transforming growth factor β1 in functioning human pancreatic carcinoid cells. J Cell Physiol 1993;156:112-8.
42. Lee JS, Newman RA, Lippman SM, et al. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J Clin Oncol 1993;11:959-66.
43. Anzano MA, Byers SW, Smith JM, et al. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamaxifen. Cancer Res 1994; 54:4614-7.
44. Warrell RP Jr. Editorial: All-trans-retinoic acid: what is it good for? J Clin Oncol 1992;10:1659-61.
45. Rees J. The molecular biology of retinoic acid receptors: orphan from good family seeks home. Br J Dermatol 1992; 126:97-104.